Yahoo
MCE - Delayed Quote EUR

Oryzon Genomics S.A. (ORY.MC)

2.3320 -0.0220 (-0.93%)
At close: November 6 at 5:35:10 PM GMT+1
View in AlphaSpace Currency in EUR All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Cost of Revenue
-15,060.9980
-10,651.9480
-7,056.5760
-13,947.9140
-15,234.1600
Gross Profit
15,060.9980
10,651.9480
7,056.5760
13,947.9140
15,234.1600
Operating Expense
20,962.6300
16,359.8900
11,479.5400
18,497.1070
20,724.0700
Operating Income
-5,901.6320
-5,707.9420
-4,422.9640
-4,549.1930
-5,489.9100
Net Non Operating Interest Income Expense
-96.2350
104.9330
-1,023.0030
-1,859.5710
-1,107.6540
Pretax Income
-5,973.8470
-5,598.4910
-5,483.7190
-6,104.0260
-6,556.5060
Tax Provision
-3,545.4480
-2,993.0220
-1,905.8960
-2,751.0830
-2,325.1030
Net Income Common Stockholders
-2,428.3990
-2,605.4690
-3,577.8230
-3,352.9430
-4,231.4030
Diluted NI Available to Com Stockholders
-2,428.3990
-2,605.4690
-3,577.8230
-3,352.9430
-4,231.4030
Basic EPS
-0.03
-0.03
-0.06
-0.06
-0.08
Diluted EPS
-0.03
-0.03
-0.06
-0.06
-0.08
Basic Average Shares
79,887.7050
77,513.0390
64,747.0810
60,879.3280
56,042.4200
Diluted Average Shares
79,887.7050
77,513.0390
64,747.0810
60,879.3280
56,042.4200
Total Operating Income as Reported
-5,902.3920
-5,710.3050
-4,422.9640
-4,549.1930
-5,489.9100
Total Expenses
5,901.6320
5,707.9420
4,422.9640
4,549.1930
5,489.9100
Net Income from Continuing & Discontinued Operation
-2,428.3990
-2,605.4690
-3,577.8230
-3,352.9430
-4,231.4030
Normalized Income
-2,423.9553
-2,569.4495
-3,611.4813
-3,506.3968
-4,105.4917
Interest Income
401.1840
713.2750
203.7210
33.9680
11.5810
Interest Expense
497.4190
608.3420
1,226.7240
1,893.5390
1,119.2350
Net Interest Income
-96.2350
104.9330
-1,023.0030
-1,859.5710
-1,107.6540
EBIT
-5,476.4280
-4,990.1490
-4,256.9950
-4,210.4870
-5,437.2710
EBITDA
-5,349.9520
-4,856.2430
-4,109.2460
-4,057.6030
-5,270.6090
Reconciled Cost of Revenue
-15,060.9980
-10,651.9480
-7,056.5760
-13,947.9140
-15,234.1600
Reconciled Depreciation
126.4760
133.9060
147.7490
152.8840
166.6620
Net Income from Continuing Operation Net Minority Interest
-2,428.3990
-2,605.4690
-3,577.8230
-3,352.9430
-4,231.4030
Total Unusual Items Excluding Goodwill
-5.9250
-48.0260
51.5880
204.6050
-195.0980
Total Unusual Items
-5.9250
-48.0260
51.5880
204.6050
-195.0980
Normalized EBITDA
-5,344.0270
-4,808.2170
-4,160.8340
-4,262.2080
-5,075.5110
Tax Rate for Calcs
0.0003
0.0003
0.0003
0.0003
0.0004
Tax Effect of Unusual Items
-1.4813
-12.0065
17.9297
51.1513
-69.1867
12/31/2022 - 12/14/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: